Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Lind · SciRah

Researcher profile · Semantic Scholar

M. Lind

Share profile

M. Lind — researcher profile on SciRah

h-index: 16
Works: 51
Citations: 1,215

Most-cited papers

Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer.
L. Seymour, D. Ferry, D. Kerr, D. Rea +15 more
2009International Journal of Oncology301 citations Open access
Semantic Scholar
Arginine Deprivation With Pegylated Arginine Deiminase in Patients With Argininosuccinate Synthetase 1–Deficient Malignant Pleural Mesothelioma: A Randomized Clinical Trial
P. Szlosarek, J. Steele, L. Nolan, D. Gilligan +28 more
2017JAMA Oncology194 citations Open access
Semantic Scholar
High procedure volume is strongly associated with improved survival after lung cancer surgery.
M. Lüchtenborg, S. P. Riaz, V. Coupland, E. Lim +6 more
2013Journal of Clinical Oncology169 citations Open access
Semantic Scholar
Survival of patients with small cell lung cancer undergoing lung resection in England, 1998–2009
M. Lüchtenborg, S. P. Riaz, E. Lim, R. Page +9 more
2013Thorax79 citations Open access
Semantic Scholar
Ifosfamide by continuous infusion to prevent encephalopathy.
T. Cerny, M. Castiglione, K. W. Brunner, A. Küpfer +2 more
1990The Lancet72 citations
Semantic Scholar
Phase II Studies of RMP-7 and Carboplatin in the Treatment of Recurrent High Grade Glioma
A. Gregor, M. Lind, H. Newman, Robert M. Grant +3 more
1999Journal of Neuro-Oncology59 citations
Semantic Scholar
Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trial.
R. Leonard, M. Lind, C. Twelves, R. Coleman +11 more
2004Journal of the National Cancer Institute56 citations Open access
Semantic Scholar
Randomized phase II study of two gemcitabine schedules for patients with impaired performance status (Karnofsky performance status </= 70) and advanced non-small-cell lung cancer.
S. Baka, L. Ashcroft, Heather Anderson, M. Lind +6 more
2005Journal of Clinical Oncology35 citations
Semantic Scholar
Gemcitabine twice weekly as a radiosensitiser for the treatment of brain metastases in patients with carcinoma: a phase I study
A. Maraveyas, J. Sgouros, S. Upadhyay, A. Abdel-Hamid +2 more
2005British Journal of Cancer33 citations Open access
Semantic Scholar
Intravenous administration of CP-4055 (ELACYT™) in patients with solid tumours. A phase I study
S. Dueland, S. Aamdal, M. Lind, H. Thomas +3 more
2009Acta oncologica29 citations Open access
Semantic Scholar
Variation in geographical treatment intensity affects survival of non-small cell lung cancer patients in England.
D. Tataru, K. Spencer, A. Bates, A. Wieczorek +4 more
2018Cancer Epidemiology24 citations Open access
Semantic Scholar
High‐dose, double alkylating agent chemotherapy with DTIC, melphalan, or ifosfamide and marrow rescue for metastatic malignant melanoma
N. Thatcher, M. Lind, G. Morgenstern, T. Carr +3 more
1989Cancer23 citations
Semantic Scholar
The care of older cancer patients in the United Kingdom
F. Gomes, A. Lewis, R. Morris, R. Parks +32 more
2020ecancermedicalscience19 citations Open access
Semantic Scholar
LungCARD - Report on worldwide research and clinical practices related to lung cancer.
R. Janković, Helena J. Goncalves, M. Čavić, C. Clemente +6 more
2019Journal of B.U.ON. : official journal of the Balkan Union of Oncology17 citations
Semantic Scholar
Comparative pharmacokinetics of escalating doses of doxorubicin in patients with metastatic breast cancer
M. Bronchud, J. Margison, A. Howell, M. Lind +2 more
2004Cancer Chemotherapy and Pharmacology17 citations
Semantic Scholar
Drug resistance, supportive care and dose intensity
E. G. D. de Vries, T. C. Hamilton, M. Lind, J. Dauplat +2 more
199316 citations Open access
Semantic Scholar
Cyclosporin associated demyelination following allogeneic bone marrow transplantation
M. Lind, L. Mcwilliam, J. Jip, J. Howard Scarffe +2 more
1989Hematological Oncology16 citations
Semantic Scholar
The effect of emergency presentation on surgery and survival in lung cancer patients in England, 2006-2008.
D. Tataru, R. Jack, M. Lind, H. Møller +1 more
2015Cancer Epidemiology13 citations Open access
Semantic Scholar
Randomized trial of arginine deprivation with pegylated arginine deiminase in patients with malignant pleural mesothelioma.
P. Szlosarek, J. Steele, L. Nolan, D. Gilligan +6 more
20149 citations
Semantic Scholar
Comparative intraperitoneal pharmacokinetics of three platinum analogues
M. Lind, D. Murphy, H. Sharma, N. Tinker +3 more
1991Cancer Chemotherapy and Pharmacology7 citations
Semantic Scholar
CAMERA - complete assessment of elderly patients with cancer: A non-randomised feasibility study.
G. Jackson, R. Gabe, Miriam J. Johnson, K. Date +4 more
2019Journal of Geriatric Oncology3 citations Open access
Semantic Scholar
A multicentre phase II pilot study of epirubicin and Taxol (paclitaxel) in patients with advanced breast cancer.
J. White, A. Howells, A. Jones, Christopher J. Poole +3 more
2000Clinics in oncology3 citations
Semantic Scholar
Advanced ovarian cancer. Drug resistance, supportive care and dose intensity.
E. G. D. de Vries, T. C. Hamilton, M. Lind, J. Dauplat +2 more
1993Annals of Oncology3 citations
Semantic Scholar
IP versus IV Pharmacokinetics in Patients Using Radiolabelled Paraplatin
H. Sharma, N. Tinker, C. Mcauliffe, M. Lind +2 more
19883 citations
Semantic Scholar
PUB068 The Applicability of Comorbidity Indices in Predicting Chemo toxicity in Non-Small Cell Lung Cancer
Boshra Edahyr, M. Lind, L. Karsera, R. Mafi +4 more
20172 citations Open access
Semantic Scholar
Pharmacokinetics of a nucleoside analogue CP-4055 in two phase I trials using a daily for 5 days schedule and three intermittent weekly or biweekly schedules
E. Raymond, S. Dueland, M. Lind, A. Awada +6 more
20052 citations
Semantic Scholar
PCH2: THE LEVEL OF HAEMOGLOBIN (Hb) IN U.K. CANCER PATIENTS CORRELATES POSITIVELY WITH QUALITY OF LIFE (QoL)
M. Lind, T. Littlewood, C. Vernon, P. Wilkinson +5 more
20002 citations Open access
Semantic Scholar
Phase I/II study of intraperitoneal iproplatin in patients with minimal residual disease following platinum-based systemic therapy for epithelial ovarian carcinoma.
D. Murphy, M. Lind, J. Prendiville, J. Renninson +4 more
1992European Journal of Cancer2 citations
Semantic Scholar
60P Real-world experience of immunotherapy in elderly cancer patients in a UK cancer centre
S. Mirza, F. Haque, S. Hodgson, M. Lind +2 more
20201 citations Open access
Semantic Scholar
A retrospective cohort study to evaluate patient survival in sarcomatoid mesothelioma receiving best supportive care, chemotherapy and palliative radiotherapy
S. Tariq, L. Oguh, L. Cawkwell, M. Lind
20181 citations
Semantic Scholar
64PDEFFECT OF COMORBIDITY ON SURGERY AND SURVIVAL AMONG LUNG CANCER PATIENTS IN ENGLAND
M. Lüchtenborg, S. P. Riaz, R. Jack, M. Peake +2 more
20151 citations Open access
Semantic Scholar
187 Survival of small cell lung cancer patients undergoing lung resection in England 1998-2009
M. Lüchtenborg, S. P. Riaz, E. Lim, R. Page +9 more
20141 citations
Semantic Scholar
A phase I dose escalation study of doxorubicin in combination with pemetrexed (Alimta (R), multitargeted antifolate).
A. Hughes, M. Lind, A. Azzabi, R. Todd +7 more
20011 citations
Semantic Scholar
Increased Numbers of Progenitor Cells in the Apheresis Product of Patients Randomised to Receive Increasing Doses of Stem Cell Factor (r-metHuSCF) Administered in Combination with Chemotherapy and a Standard Dose of Filgrastim (r-metHuG-CSF)
A. Weaver, P. Woll, M. Lind, B. Jenkins +4 more
19981 citations
Semantic Scholar
Phase II study of intravenous RMP-7 and carboplatin for chemotherapy naïve recurrent malignant glioma
A. Gregor, M. Lind, C. Osbom
19971 citations
Semantic Scholar
Etoposide phosphate (EP): A comparative intrapatient bio-equivalence study with etoposide(E)
N. Bailey, M. Millward, Newell, C. Charlton +9 more
19931 citations
Semantic Scholar
The Manchester Experience with Ifosfamide and Mesna in Lung Cancer
N. Thatcher, M. Lind, H. Anderson, W. Steward +3 more
19891 citations
Semantic Scholar
Niraparib efficacy in patients with unresectable mesothelioma: a randomised phase II trial of niraparib versus active symptom control in patients with previously treated mesothelioma: NERO (TRIALS IN PROGRESS)
D. Fennell, D. Griffiths, Z. Eminton, Abigail Morgan-Fox +24 more
2023Lung Cancer0 citations
Semantic Scholar
Safety of pembrolizumab in patients with non-small cell lung cancer: a real-world study
D. Thakrar, B. Essang, A. Echlin, C. Murdock +1 more
2019Lung Cancer0 citations
Semantic Scholar
A retrospective study of maintenance pemetrexed in advanced non-squamous non-small cell lung cancer
L. Oguh, D. Ranatunge, M. Lind, S. Upadhyay +1 more
20180 citations
Semantic Scholar
P3.07-011 Geographical Variation in the Use of Radiotherapy and Surgical Resection for Treatment of Non-Small Cell Lung Cancer in England: Topic: Other – Geographical Differences
D. Tataru, Katie Spencer, R. Jack, A. Bates +3 more
20170 citations Open access
Semantic Scholar
Quality improvement project addressing small cell lung cancer wait time from histological diagnosis to first treatment
L. Karsera, M. Lind
2016Future Hospital Journal0 citations Open access
Semantic Scholar
209 High procedure volume is strongly associated with improved survival after lung cancer surgery
M. Lüchtenborg, S. P. Riaz, V. Coupland, E. Lim +6 more
20140 citations Open access
Semantic Scholar
221 A randomized phase II trial of pegylated arginine deaminase (ADI-PEG 20) in patients with malignant pleural mesothelioma
P. Szlosarek, D. Fennell, R. Rudd, M. Lind +4 more
20060 citations
Semantic Scholar
A randomized phase II trial of pegylated arginine deaminase (ADI-PEG 20) in patients with malignant pleural mesothelioma
P. Szlosarek, D. Fennell, R. Rudd, M. Lind +4 more
20060 citations
Semantic Scholar
Levomepromazine (nozinan) has efficacy in delayed chemotherapy induced emesis (DCIE) following platinum-based treatment
H. Mccabe, M. Lind, S. Wilkinson, A. Maraveyas
20010 citations
Semantic Scholar
Stem cell factor (r-metHuSCF) in combination with filgrastim (r-metHuG-CSF) enhances peripheral blood progenitor cell (PBPC) mobilisation following chemotherapy: A randomised study
A. Weaver, P. Woll, M. Lind, C. Gill +4 more
19970 citations
Semantic Scholar
The mobilisation of peripheral blood progenitor cells using chemotherapy, stem cell factor and filgrastim or chemotherapy plus filgrastim alone: a randomised study.
A. Weaver, P. Woll, M. Lind, B. Jenkins +4 more
1997Sangre0 citations
Semantic Scholar
COMPARISON OF MYELOTOXICITY RELATING TO 2 CHEMOTHERAPY REGIMENS FOR SMALL-CELL LUNG-CANCER (SCLC)
D. Fishwick, E. Loughney, M. Lind, H. Calvert +2 more
19930 citations
Semantic Scholar
A phase-II study of ifosfamide and alpha-2 interferon (intron-A) in advanced non-small cell lung-cancer
M. Lind, N. Thatcher, H. Gurney, A. Kamthan
19900 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Lüchtenborg×8
Invite
M. Lüchtenborg — researcher profile on SciRah
M. Peake×6
Invite
M. Peake — researcher profile on SciRah
H. Møller×6
Invite
H. Møller — researcher profile on SciRah
P. Szlosarek×5
Invite
P. Szlosarek — researcher profile on SciRah

×5

Invite

S. P. Riaz — researcher profile on SciRah

Invite

J. Spicer — researcher profile on SciRah

J. Bomalaski×4

Invite

J. Bomalaski — researcher profile on SciRah

Invite

D. Fennell — researcher profile on SciRah

Invite

A. Hackshaw — researcher profile on SciRah

Invite

E. Lim — researcher profile on SciRah

Invite

E. Jakobsen — researcher profile on SciRah

Invite

R. Page — researcher profile on SciRah